# Medrhythms

> Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. Last analyzed September 24, 2026.

> MedRhythms develops next-generation neurotherapeutics, leveraging a proprietary and patented technology platform that combines sensors, software, and music with advanced neuroscience. Rooted in Rhythmic Auditory Stimulation (RAS), its digital therapeutics aim to improve walking, mobility, and functional outcomes for individuals with neurological conditions such as stroke, multiple sclerosis, and Parkinson's disease.

- Business Profile: https://optimly.ai/brand/medrhythms
- Publisher: Optimly (https://optimly.ai)
- Dataset: Optimly AI Brand Index (https://optimly.ai/brand)
- Official website: https://medrhythms.com/
- Logo: https://logo.clearbit.com/medrhythms.com
- Slug: medrhythms
- Brand Authority Index tier: Emerging
- Category: Digital Therapeutics (DTx) Platforms
- Last Analyzed: September 24, 2026

## Buyer Intent Signals
Problems: persistent walking deficits | walking disability decreases independence | reduced quality of life due to walking issues | increased falls risk | healthcare system burden from walking disability | neurologic diseases and injuries causing walking impairments | limited access to specialized neurologic music therapy clinicians
Solutions: improve walking and mobility | redefine brain health possibilities | transformative and innovative therapeutics | digital therapeutics for neurological conditions | rhythmic auditory stimulation (RAS) based interventions | technology platform for neurotherapeutics | music-based therapy for neurological gait disorders | prescription digital health solutions
Comparisons: efficacy of music to improve movement | clinical research studies on RAS | patented technology platform | neuroscience and technology integration | curated and screened music content for therapy | advanced training in clinical application of neuroscience and music | collaboration with Universal Music Group